usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Zepbound® - Injectable -

S., & Choi, H

Mirum CEO Chris Peetz said in a statement that Livmarli could have a transformational impact for patients with cholestatic pruritis associated with PFIC. March 11: In a press release Monday, Viatris and Mapi Pharma announced that the FDA has rejected their multiple sclerosis hopeful GA Depot 40, which the companies had proposed as a treatment for relapsing forms of the disease

doi: 10.3389/fphar.2021.570520 508 CeccarelliGStatzuMSantinelliLPinacchioCBitossiCCavallariENet al

Understanding variants in liver metabolism, glucose control, and GI motility enables your care team to provide personalized alcohol guidelines beyond generic recommendations

The only surprise here is the timing

This is especially important for older people with type 2 diabetes, as they have an increased risk of osteoporosis and fractures (65)